Categories
Anti Cancer cancer research Cancer Treratments drug repurposing integrative-oncology Ivermectin Mebendazole Mission & Vision preclinical trial Repurposed Drug Studies Research & Science

The Synergy Puzzle: Could Ivermectin and Mebendazole Work With Standard Care?

The future of cancer treatment lies in combination. Discover the compelling science suggesting how repurposed drugs like ivermectin and mebendazole could work synergistically with standard therapies to improve outcomes and overcome treatment resistance.

Categories
Anti Cancer cancer research Cancer Treratments drug repurposing integrative-oncology Mission & Vision preclinical trial Research & Science

Navigating the Unknown: A Patient’s Guide to “Right-to-Try” and Repurposed Therapies

Facing limited options? This guide helps patients and caregivers navigate the difficult path of considering repurposed drugs, emphasizing safety, open communication with your oncologist, and informed decision-making.

Categories
Anti Cancer cancer research Cancer Treratments drug repurposing integrative-oncology Mission & Vision preclinical trial Repurposed Drug Studies Research & Science

Beyond the Hype & The Headlines: Reclaiming the Conversation on Repurposed Drugs

In a landscape dominated by hype and headlines, our foundation is dedicated to a single, clear mission: moving the conversation about repurposed drugs like ivermectin and mebendazole from anecdote to evidence through rigorous, independent science.

Categories
Anti Cancer Cancer Treratments chemotherapy Fenbendazole Ivermectin Mebendazole Natural Treatments preclinical trial

A New Dawn: Courage Against Cancer Funds Its First Preclinical Trial on the Path to FDA Approval

Courage Against Cancer announces a major milestone: funding our first preclinical trial for ivermectin and mebendazole. This is the critical first step on our rigorous path to achieve FDA approval and create a new, accessible paradigm in cancer therapy.